IRIS UniCatt

Tolusso, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.538
EU - Europa 4.060
AS - Asia 3.293
SA - Sud America 751
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 8
AN - Antartide 2
Totale 12.774
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.411
SG - Singapore 1.585
DE - Germania 901
CN - Cina 891
IT - Italia 696
BR - Brasile 635
SE - Svezia 596
PL - Polonia 521
FR - Francia 372
GB - Regno Unito 188
VN - Vietnam 184
IE - Irlanda 180
UA - Ucraina 168
IN - India 141
FI - Finlandia 129
ID - Indonesia 117
RU - Federazione Russa 79
CA - Canada 65
HK - Hong Kong 65
BD - Bangladesh 53
TR - Turchia 51
BE - Belgio 48
AR - Argentina 47
MX - Messico 45
NL - Olanda 43
JP - Giappone 39
ZA - Sudafrica 36
IQ - Iraq 35
KR - Corea 29
AT - Austria 28
CI - Costa d'Avorio 27
VE - Venezuela 17
CZ - Repubblica Ceca 15
ES - Italia 14
CH - Svizzera 13
LT - Lituania 13
MA - Marocco 13
SA - Arabia Saudita 13
EC - Ecuador 12
CO - Colombia 11
IR - Iran 11
PK - Pakistan 11
UZ - Uzbekistan 10
IL - Israele 8
KE - Kenya 8
PY - Paraguay 8
RO - Romania 8
AU - Australia 7
PE - Perù 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
GR - Grecia 6
JM - Giamaica 6
JO - Giordania 6
UY - Uruguay 6
CL - Cile 5
EE - Estonia 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
BG - Bulgaria 4
DK - Danimarca 4
DZ - Algeria 4
HU - Ungheria 4
LK - Sri Lanka 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BO - Bolivia 3
CR - Costa Rica 3
KH - Cambogia 3
NG - Nigeria 3
NP - Nepal 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AM - Armenia 2
AQ - Antartide 2
AZ - Azerbaigian 2
EG - Egitto 2
GA - Gabon 2
GE - Georgia 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
SN - Senegal 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
Totale 12.762
Salva come PNG Salva come JPEG
Città #
Singapore 765
Chandler 640
Warsaw 475
Ashburn 442
Fairfield 191
Beijing 186
New York 169
Ann Arbor 165
Dublin 165
Dearborn 150
Rome 144
Wilmington 126
Woodbridge 120
Seattle 113
Jakarta 110
Dallas 107
Jacksonville 103
Los Angeles 100
Nanjing 100
Milan 99
Munich 99
Hefei 97
San Mateo 94
Houston 85
Cattolica 78
The Dalles 72
Chicago 68
Boston 66
Hong Kong 64
Cambridge 62
Frankfurt am Main 57
Ho Chi Minh City 56
São Paulo 54
Hanoi 53
Bremen 51
Princeton 51
Helsinki 49
Marseille 43
Brussels 42
London 37
Moscow 37
Nürnberg 32
Lawrence 31
Redwood City 30
Tokyo 30
Izmir 29
North Bergen 29
Buffalo 28
Turku 28
Abidjan 27
Pune 27
Seoul 27
Boardman 23
Norwalk 23
Kent 22
Kraków 22
Redmond 21
Tianjin 21
Kunming 20
Lancaster 20
Nanchang 20
Nuremberg 20
Phoenix 19
Denver 18
Montreal 18
Toronto 18
Santa Clara 17
Brasília 16
Hebei 16
Lappeenranta 16
Mexico City 16
Rio de Janeiro 16
Atlanta 15
Baghdad 15
Hangzhou 15
Johannesburg 15
Mountain View 15
San Francisco 15
Leawood 14
Poplar 14
Portsmouth 14
Shenyang 14
Stockholm 14
Amsterdam 13
Brooklyn 13
Busto Arsizio 13
Chennai 13
Roubaix 13
Santa Maria 13
Vienna 13
Curitiba 12
Falls Church 12
Jiaxing 12
Augusta 11
Düsseldorf 11
Manchester 11
Washington 11
Wroclaw 11
Andover 10
Brno 10
Totale 6.847
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 421
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 327
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 323
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 293
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 287
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 244
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 243
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 207
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 194
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 193
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 179
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 178
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 174
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 171
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 171
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 167
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 158
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 157
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 153
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 153
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 152
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 151
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 145
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 145
COVID-19 atypical Parsonage-Turner syndrome: a case report 144
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 144
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 138
Malnutrition in COVID-19 survivors: prevalence and risk factors 137
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 137
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 137
Sarilumab use in severe SARS-CoV-2 pneumonia 134
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 132
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 128
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 127
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 126
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 125
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 125
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 124
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 121
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 117
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 116
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 114
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 113
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 113
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 112
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 111
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 111
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 110
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 105
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 103
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 102
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 102
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 101
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 100
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 100
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 99
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 98
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 98
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 98
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 96
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 95
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 94
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 92
Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve (Endocrine, (2019), 63, 2, (369-375), 10.1007/s12020-018-1783-1) 91
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 89
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 89
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 88
Is it necessary to be citrullinated to have restricted clonotypes reacting with Collagen type II? Comment to article "A novel HLA-DRB1*10:01 restricted T cell epitope from citrullinated type II collagen relevant for Rheumatoid Arthritis" 88
Beetroot juice intake positively influenced gut microbiota and inflammation but failed to improve functional outcomes in adults with long COVID: A pilot randomized controlled trial 87
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 87
Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve 87
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 87
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 86
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 86
Weight Loss, The Obesity Paradox in Rheumatoid Arthritis: Is It a Paradox? Comment on the Article by Baker et al 85
Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role? 85
Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES 83
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: A case report 83
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study. 81
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 81
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 80
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis 78
The B side of rheumatoid arthritis pathogenesis 78
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 78
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study 77
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 76
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 76
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 75
Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs 74
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 72
Mitochondria-Derived Vesicles and Inflammatory Profiles of Adults with Long COVID Supplemented with Red Beetroot Juice: Secondary Analysis of a Randomized Controlled Trial 71
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 71
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 70
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 70
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 66
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 65
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 64
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 60
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 59
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 57
Totale 12.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.169
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021418 0 0 0 0 0 37 78 12 92 70 100 29
2021/2022915 119 62 38 61 65 29 28 103 41 67 133 169
2022/20231.893 220 239 150 300 117 224 92 140 235 62 63 51
2023/20241.112 42 253 46 64 45 189 81 52 14 78 160 88
2024/20252.397 48 47 176 94 200 91 101 98 357 263 476 446
2025/20263.173 840 224 404 689 931 85 0 0 0 0 0 0
Totale 12.955